CN1641351A - Human brain red protein detecting and diagnostic kit, and its preparing method and use - Google Patents
Human brain red protein detecting and diagnostic kit, and its preparing method and use Download PDFInfo
- Publication number
- CN1641351A CN1641351A CN 200310113502 CN200310113502A CN1641351A CN 1641351 A CN1641351 A CN 1641351A CN 200310113502 CN200310113502 CN 200310113502 CN 200310113502 A CN200310113502 A CN 200310113502A CN 1641351 A CN1641351 A CN 1641351A
- Authority
- CN
- China
- Prior art keywords
- ngb
- kit
- antibody
- bottle
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Landscapes
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
The invention provides a novel human NGB detecting and diagnosing reagent box, and its manufacturing method and use. This reagent box is composed of solid-phase carrier as well as monoclonal antibody, multiclonal antibody and standard NGB product, etc; its preparing method include the steps of preparing antigen and antibody, purifying antibody, packaging reagent box. It has higher sensitivity and can be applied to detecting the content of NGB in sample, and provide effective detecting means for early diagnosis and course of diseases such as epileptic dementia, cerebral infarction, traumatic brain damage, etc.
Description
Technical field the present invention relates to a kind of immune detection and diagnostic reagent, is specifically related to a kind of Novel Human NGB enzyme linked immunosorbent detection and diagnostic kit, also relates to Preparation Method And The Use.
The background technology NGB (Neuroglobin, NGB) be in the body the 3rd class except haemoglobin and myoglobins important take oxygen albumen, specifically expressing in nervous system is distributed widely in the brain tissue.The same with myoglobins, NGB can be reversibly in conjunction with oxygen, and with oxygen very high affinity is arranged.Myoglobins is atomic at the normal human serum intensive amount, and when cardiac muscle and Skeletal muscle injury, myoglobins can discharge from damaged cell, goes into blood fast, causes serum myoglobin to raise.Myoglobins has become responsive and special biochemical diagnosis index such as some important diseases such as miocardial infarction, renal failure clinically.NGB and myoglobins are in function and have strict similarity in nature: NGB has 151 amino acid, and molecular weight is 17 kilodaltons, and myoglobins then has 154 amino acid, and molecular weight also is 17 kilodaltons.In view of NGB and myoglobins have strict similarity on function, it is the oxygen supply that myoglobins is responsible for cardiac muscle and skeletal muscle, NGB then is responsible for the oxygen supply of brain, both all can be released into blood from damaging cells, therefore, NGB relates at senile dementia, cerebral infarction, traumatic brain injury etc. in the early diagnosis of diseases such as neure damage and sex change death has potential diagnostic value, the course of disease in the above-mentioned disease treatment process is followed the tracks of also to have important value simultaneously.
Summary of the invention the invention provides a kind of Novel Human NGB ELISA measuring reagent kit.This kit is by one of 96 hole ELISA Plate, 1 bottle of NGB standard items, 1 bottle of NGB monoclonal antibody, 1 bottle of stop buffer of concentrated cleaning solution (sulfuric acid solution (H of 2M that 1 bottle of NGB polyclonal antibody, horseradish peroxidase (HRP)-1 bottle of goat anti-rabbit immunoglobulin (IgG), o-phenylenediamine (OPD) are 2 bottles, 20 times
2SO
4)) 1 bottle of composition.Wherein the HRP-goat anti-rabbit igg is a middle mountain company product.The invention also discloses preparation method, using method of kit and uses thereof.
This kit of purposes has higher sensitivity, can be used for the content of NGB in the test sample, and can be senile dementia, cerebral infarction, traumatic brain injury etc. and relate to early diagnosis in the diseases such as neure damage and sex change death and the course of disease in the therapeutic process and follow the tracks of effective detection means is provided.
Below needing, the use of this kit of preparation method provides reagent for oneself:
1) wrap diluted liquid (the 0.05mol/L carbonate buffer solution, pH9.6): Na
2CO
31.5g+NaHCO
32.9g be dissolved in distilled water, add distilled water and replenish volume to 1000ml.
2) phosphate buffer (PBS, 0.02M, pH7.4): NaCl 16.0g+NaH
2PO
42H
2O 0.593g+Na
2HPO
412H
2O 5.8g adds distilled water to 2000ml.
3) sample dilution: PBS 100ml+0.1g BSA+50 μ l Tween 20.
4) confining liquid (5% skimmed milk-PBS solution): 50g skimmed milk+PBS to 1000ml.
5) substrate buffer solution: A liquid (0.1mol/L citric acid solution): citric acid 19.2g adds distilled water to 1000ml; B liquid (0.2mol/L Na
2HPO
4): Na
2HPO
412H
2O 71.7g adds distilled water to 1000ml; Face with before getting A liquid 24.3ml, B liquid 25.7ml and mix.
6)30%H
2O
2?500ml。
The preparation method that this kit is concrete:
1) preparation of antigen: the prokaryotic expression carrier pGEX-4T-2 transformed into escherichia coli BL21 that will be built with the NGB gene coding region, by isopropyl-(isopropyl-1-thio-D-galactopyranoside, IPTG) abduction delivering, obtain the solubility expression product, with behind glutathione S-transferase (GST) the affinity column purifying as antigen (Fig. 1, Fig. 2).
2) the antigen immune Balb/c mouse of preparation prepares anti-NGB monoclonal antibody by traditional cell fusion method the preparation of antibody: with 1), simultaneously immunizing rabbit prepare anti-NGB polyclonal antibody (Fig. 3, Fig. 4).
3) purifying antibody: with 2) antibody of gained through centrifugal, precipitation, desalination, slightly carry antibody, through Protein G post affinity purification, promptly get antibody purification then.
4) preparation of kit:, be divided in bottle or the conical centrifuge tube by the kit requirement with 8 kinds of compositions of kit.
5) specificity of identification kit, sensitivity, precision, qualified stability (Fig. 7).
The using method of this kit of using method is as follows:
1) the bag quilt of antibody: the monoclonal antibody (10 μ g/ml) of the anti-NGB of coating buffer dilution is added in the 96 hole ELISA Plate, every hole 100 μ l, 4 ℃ are spent the night, cleansing solution washing 1 time, each 3 minutes.Add confining liquid 200 μ l/ holes, 40 ℃ of sealings 50~60 minutes (or 4 ℃ spend the night).Sealing finishes the back and washes plate 3 times with cleansing solution, each 3 minutes.
2) add sample: will contain the testing sample and the standard NGB albumen (5.76ng/ml, 28.8ng/ml, 144ng/ml, 720ng/ml, 3.6 μ g/ml, 18 μ g/ml) that suitably dilute by 0.1% BSA and 0.05% tween (Tween), 20 sample diluting liquids and add enzyme reaction plate (100 μ l/ hole) respectively, place 40 ℃ of incubations 1 hour.Discard liquid in the hole, cleansing solution is washed plate 3 times, each 3 minutes.
3) add the anti-NGB polyclonal antibody of rabbit: get and contain the anti-NGB polyclonal antibody of rabbit (1: 500) of suitable dilution of 0.1% BSA and 0.05% polysorbas20 sample diluting liquid, add in the ELISA Plate (100 μ l/ hole), placed 40 ℃ of incubations 30 minutes.Discard liquid in the hole, cleansing solution is washed plate 3 times, each 3 minutes.
4) add the HRP-goat anti-rabbit igg: get the suitableeest dilution HRP-goat anti-rabbit igg (1: 5000), add 100 μ l/ holes in the ELISA Plate, placed 40 ℃ of incubations 40 minutes.Discard liquid in the hole, cleansing solution is washed plate 3 times, each 3 minutes.
5) colour developing: get substrate solution A liquid 24.3ml and B liquid 25.7ml and mix, add o-phenylenediamine, add 30%H at last to concentration 4~10mg/ml
2O
2Solution 25~50 μ l.Get freshly prepared substrate buffer solution 100 μ l/ holes and add reaction plate.Room temperature lucifuge reaction 5~10 minutes.
6) cessation reaction: when positive control obvious change color or negative control occurred and slightly develops the color, every hole added stop buffer 50 μ l cessation reactions.
7) result calculates: measure absorbance value (A) at the 492nm place.With standard protein concentration as horizontal ordinate, the standard protein hole A that records
492nmValue is ordinate, drawing standard curve.Check in the NGB content of testing sample by typical curve, multiply by extension rate again, promptly get the actual content in the testing sample.
Description of drawings
Fig. 1: the expression of results of fusion GST-NGB.Swimming lane 1: the total protein of expressing among the Escherichia coli E.coli (DE3) behind the transfection empty carrier pGEX-4T-2; Swimming lane 2:, obtain the GST protein sample with expressed proteins among the Escherichia coli E.coli (DE3) behind the GST affinity column purifying transfection empty carrier pGEX-4T-2.Swimming lane 3: the total protein of expressing among the Escherichia coli E.coli (DE3) behind the transfection expression carrier pGEX-4T-2/NGB; Swimming lane 4: with the GST-NGB fusion of GST affinity column purifying acquisition; Swimming lane 5: molecular weight marker in the protein.
After Fig. 2: GST-NGB cuts through the fibrin ferment enzyme, the NGB albumen that obtains.Swimming lane 1: molecular weight marker in the protein; After swimming lane 2:GST-NGB cuts through the fibrin ferment enzyme, the NGB sample that obtains.
Fig. 3: the Quality Identification of mouse anti NGB monoclonal antibody.Using Western blotting technology detects the monoclonal antibody that obtains, the proof monoclonal antibody has very high specificity, each strain antibody all can combine with NGB and GST-NGB, and reactionless with GST and mycoprotein, and detects the eukaryotic expression product (GFP-NGB) of NGB specifically.
Fig. 4: the hypotype of prepared mouse anti NGB monoclonal antibody is identified in this kit.Through identifying, confirm the anti-NGB monoclonal antibody of four strains 3G8,3H2,2E7, the heavy chain of 1E12 is IgG1, and light chain is the κ chain.
Fig. 5: the Quality Identification of the anti-NGB polyclonal antibody of rabbit: the anti-NGB polyclonal antibody of rabbit can detect the NGB albumen of expressing in the eukaryotic.Method: after using expression vector pcDNA3.1/V5/6 * His/NGB, pcDNA3.1/V5/6 * His/LacZ and empty carrier transfection COS-7 cell respectively, the total protein of cell behind the collection transfection 48h, Western blotting detects.Swimming lane 1: the anti-NGB polyclonal antibody of rabbit can detect the band of about 20kDa; Swimming lane 2: negative control, the empty carrier rotaring redyeing COS 7 cell fails to detect any band with the anti-NGB polyclonal antibody of rabbit; Swimming lane 3: can detect NGB-6 * His amalgamation and expression albumen with anti-6 * His monoclonal antibody; Swimming lane 4: positive control: can detect LacZ-6 * His amalgamation and expression albumen with anti-6 * His monoclonal antibody.
Fig. 6: the Quality Identification of the anti-NGB polyclonal antibody of rabbit.Detect the Tissue distribution of NGB in Adult Rat Brain with the anti-NGB polyclonal antibody of rabbit prepared in this kit, visible NGB immune response positive cell is distributed widely in each district (CA of hippocampus
1, CA
2, CA
3, CA
4) in pyramidal cell layer and cerebellum purkinje cell and the cell process thereof.
Fig. 7: the typical curve of this kit.The concentration range that can detect NGB concentration is at 5.76ng/ml~18 μ g/ml.
Claims (5)
1. a Novel Human NGB detects and diagnostic kit, it is characterized in that this kit is mainly by 1 of 96 hole ELISA Plate, 1 bottle of NGB standard items, 1 bottle of NGB monoclonal antibody, 1 bottle of NGB polyclonal antibody, 1 bottle of negative control, the goat anti-rabbit immunoglobulin G1 bottle of horseradish peroxidase-labeled, 1 bottle of 2 bottles, 20 times concentrated cleaning solution of o-phenylenediamine and stop buffer (2M sulfuric acid solution (H
2SO
4)) 1 bottle of composition.
2. the preparation method of the described kit of claim 1 is characterized in that comprising the steps:
1) preparation of antigen: will be built with the prokaryotic expression carrier transformed into escherichia coli of NGB gene coding region, obtain the solubility expression product, behind the affinity column purifying as antigen.
2) the antigen immune Balb/c mouse of preparation prepares anti-NGB monoclonal antibody by traditional cell fusion method the preparation of antibody: with 1), and immunizing rabbit prepares anti-NGB polyclonal antibody simultaneously.
3) purifying antibody: with 2) monoclonal antibody of gained through centrifugal, precipitation, desalination, slightly carry antibody, then through affinity purification, promptly get antibody purification.
4) assembling of kit: will form 8 kinds of compositions of kit, and be divided in bottle or the conical centrifuge tube by the kit requirement.
5) specificity of identification kit, sensitivity, precision, stability.
3. the described a kind of Novel Human NGB of claim 1 detects and diagnostic kit, it is characterized in that the concentration range of the NGB that can detect be: 5.76ng/ml~18 μ g/ml.
4. the described a kind of Novel Human NGB of claim 1 detects and diagnostic kit, it is characterized in that wherein said negative controls is a normal human serum, and dense cleansing solution is phosphoric acid-Tween-20.
5. the described a kind of Novel Human NGB of claim 1 detects and diagnostic kit the purposes in detecting NGB.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2003101135027A CN100489526C (en) | 2004-01-16 | 2004-01-16 | Human brain red protein detecting and diagnostic kit, and its preparing method and use |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2003101135027A CN100489526C (en) | 2004-01-16 | 2004-01-16 | Human brain red protein detecting and diagnostic kit, and its preparing method and use |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1641351A true CN1641351A (en) | 2005-07-20 |
CN100489526C CN100489526C (en) | 2009-05-20 |
Family
ID=34866378
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2003101135027A Expired - Fee Related CN100489526C (en) | 2004-01-16 | 2004-01-16 | Human brain red protein detecting and diagnostic kit, and its preparing method and use |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100489526C (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106053852A (en) * | 2015-11-29 | 2016-10-26 | 卢美珍 | Kit for detecting human brain diseases |
CN106117357A (en) * | 2016-06-29 | 2016-11-16 | 烟台正海生物科技股份有限公司 | BMP 2 antibody and the application in BMP 2 protein content in detection bone renovating material thereof |
CN106771234A (en) * | 2016-12-05 | 2017-05-31 | 广州华弘生物科技有限公司 | A kind of method of utilization double-antibody method quantitative determination NGB and its application |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5624804A (en) * | 1991-12-20 | 1997-04-29 | The Rockefeller University | Immunochemical detection of In vivo advanced glycosylation end products |
CN1214106C (en) * | 1999-02-22 | 2005-08-10 | 爱科来株式会社 | Novel enzyme |
WO2003013507A1 (en) * | 2001-08-09 | 2003-02-20 | The United States Of America As Represented By Department Of Veterans Affairs | Method of preventing or reducing the occurrence of symptoms of psychosis |
WO2003040332A2 (en) * | 2001-11-06 | 2003-05-15 | Buck Institute | Neuroglobin is up-regulated by and protects neuronsfrom hypoxic-ischemic injury |
-
2004
- 2004-01-16 CN CNB2003101135027A patent/CN100489526C/en not_active Expired - Fee Related
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106053852A (en) * | 2015-11-29 | 2016-10-26 | 卢美珍 | Kit for detecting human brain diseases |
CN106117357A (en) * | 2016-06-29 | 2016-11-16 | 烟台正海生物科技股份有限公司 | BMP 2 antibody and the application in BMP 2 protein content in detection bone renovating material thereof |
CN106117357B (en) * | 2016-06-29 | 2019-08-30 | 烟台正海生物科技股份有限公司 | BMP-2 antibody and its application in detection bone renovating material in BMP-2 protein content |
CN106771234A (en) * | 2016-12-05 | 2017-05-31 | 广州华弘生物科技有限公司 | A kind of method of utilization double-antibody method quantitative determination NGB and its application |
Also Published As
Publication number | Publication date |
---|---|
CN100489526C (en) | 2009-05-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Cressman et al. | Lipoprotein (a) is an independent risk factor for cardiovascular disease in hemodialysis patients. | |
US5573957A (en) | Monoclonal antibody to human cardiac myoglobin | |
CN101215323B (en) | Human AD7C-NTP antigen determinant polypeptide, antibody and application thereof in diagnosis kit | |
EP2074430B1 (en) | Methods and means for determining platelet function and diagnosing platelet- related and cardiovascular disorders | |
JPH10511185A (en) | Method and apparatus for diagnosing and differentiating chest pain early in its onset | |
KR101669918B1 (en) | Method for measuring cystatin c in human body fluid | |
CN107533048A (en) | For diagnosing the method and composition of brain damage or neurodegeneration | |
CN101806804A (en) | Reagent for detecting acute myocardial infarction by immunological method and test strip | |
CN101738473A (en) | Treponema pallidum antibody diagnostic kit and preparation method thereof | |
Eng et al. | Immunogenicity of venoms from four common snakes in the South of Vietnam and development of ELISA kit for venom detection | |
JPH09511915A (en) | Monoclonal antibody against human ventricular myosin light chain | |
CN107602698A (en) | New monoclonal antibody and the immunological assay method of D dimer | |
Head et al. | Expression of phosphatidylserine (PS) on wild‐type and Gerbich variant erythrocytes following glycophorin‐C (GPC) ligation | |
Mouliou | C-reactive protein: pathophysiology, diagnosis, false test results and a novel diagnostic algorithm for clinicians | |
CN100489526C (en) | Human brain red protein detecting and diagnostic kit, and its preparing method and use | |
EP0557663A1 (en) | Assessment of bone fragility and prediction of osteoporotic fracture risk using a quantitative determination of circulating under-carboxylated osteocalcin | |
ZA200109544B (en) | Diagnosis and treatment of atherosclerosis and coronary heart disease. | |
US20140193843A1 (en) | Use of basic prolin-rich lacrimal gene products, such as opiorphin, as a biomarker | |
CN2676202Y (en) | Early fast detection test paper for acute myocardial infarction | |
AU674623B2 (en) | Purified stable liquid prealbumin | |
Belous et al. | The state of the serotonin transporter protein in the platelets of patients with somatoform disorders | |
Pukrittayakamee et al. | A competitive radioimmunoassay using a monoclonal antibody to detect the factor X activator of Russell's viper venom | |
Stigbrand et al. | A new specific method for measuring S-100B in serum | |
CN107002065A (en) | To TRACP 5b(Tartaric acid repellence acid phosphatase 5b)With specific albuminimetry | |
US6004765A (en) | Assessment of bone fragility and prediction of osteoporotic fracture risk using a quantitative determination of circulating under-carboxylated osteocalcin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20090520 Termination date: 20130116 |